FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Sanchez Altura Victor

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2015 

3. Issuer Name and Ticker or Trading Symbol

Pharma-Bio Serv, Inc. [PBSV]

(Last)        (First)        (Middle)

C/O PHARMA-BIO SERV, INC., 6 ROAD 696

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
President and CEO /

(Street)

DORADO, PR 00646       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option     (1) 1/30/2017   Common Stock   100000   $.72   D    
Restricted Stock Units     (2)   (2) Common Stock   25000     (3) D    

Explanation of Responses:
( 1)  The stock option becomes exercisable in three equal annual installments beginning on January 30, 2013.
( 2)  The restricted stock units vest in three equal annual installments beginning on January 14, 2015. Vested shares will be issued to the reporting person within thirty days following the vesting of the restricted stock units.
( 3)  Each restricted stock unit represents a contingent right to receive one share of Pharma-Bio Serv, Inc. common stock.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Sanchez Altura Victor
C/O PHARMA-BIO SERV, INC.
6 ROAD 696
DORADO, PR 00646

President and CEO

Signatures
/s/ Victor Sanchez 1/9/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Pharma Bio Serv (QB).
Pharma Bio Serv (QB) (USOTC:PBSV)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Pharma Bio Serv (QB).